Detalhe da pesquisa
1.
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A.
Blood
; 141(10): 1147-1158, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108308
2.
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform.
Haemophilia
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698539
3.
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patients.
Haemophilia
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38738967
4.
Health utilities in adults with hemophilia A: A retrospective cohort study.
Haemophilia
; 30(3): 733-742, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506967
5.
Canadian clinical experience on switching from standard half-life recombinant factor VIII (rFVIII), octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada.
Haemophilia
; 30(2): 345-354, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38379181
6.
Test-retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study.
Haemophilia
; 30(3): 702-708, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439137
7.
Cost-utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada.
Haemophilia
; 29(2): 488-497, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528890
8.
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.
Haemophilia
; 29(1): 33-44, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224704
9.
Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review.
Haemophilia
; 29(4): 954-962, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289855
10.
Reported prevalence of von Willebrand disease worldwide in relation to income classification.
Haemophilia
; 29(4): 975-986, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276350
11.
Von Willebrand Disease: Gaining a global perspective.
Haemophilia
; 29(4): 1104-1112, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216656
12.
Deep learning to refine the identification of high-quality clinical research articles from the biomedical literature: Performance evaluation.
J Biomed Inform
; 142: 104384, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164244
13.
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.
Blood
; 135(20): 1788-1810, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32092132
14.
Emicizumab state-of-the-art update.
Haemophilia
; 28 Suppl 4: 103-110, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35521723
15.
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics.
Haemophilia
; 28(6): e237-e244, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939628
16.
Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers.
Haemophilia
; 28(1): 36-41, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784071
17.
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders.
Eur J Haematol
; 108(3): 232-243, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878676
18.
Overall prognosis of preschool autism spectrum disorder diagnoses.
Cochrane Database Syst Rev
; 9: CD012749, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169177
19.
Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature.
J Med Internet Res
; 24(1): e30791, 2022 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060915
20.
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time.
Haemophilia
; 27(5): e596-e608, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145693